CMS looks to expand Medicare coverage to CAR-T therapy by Paige Minemyer Friday, February 15, 2019 CMS plans to allow Medicare to cover an emerging immunotherapy for cancer patients, it announced on Friday.
FDA approved record number of personalized medicines in 2018 by Jacqueline Renfrow Wednesday, February 13, 2019 The number of FDA-approved therapies for personalized medicines has jumped from 20% to 40% in the last few years.
WindRose Health raises $705M in 5th fund—roundup by Paige Minemyer Tuesday, January 8, 2019 Healthcare PE firm WindRose took in $705 million in its fifth fund, plus more healthcare headlines.
Ascension Texas to reopen Little River facilities—roundup by Paige Minemyer Tuesday, January 8, 2019 Ascension has acquired providers and clinics associated with Little River Healthcare, plus more healthcare headlines.
Why Sean Parker thinks cell therapy is the future of oncology by Paige Minemyer Wednesday, November 21, 2018 Billionaire philanthropist Sean Parker explains why he's so bullish on cell therapy as part of his Parker Institute for Cancer Immunotherapy.
CMS to allow states to waive Medicaid IMD exclusion—roundup by Paige Minemyer Tuesday, November 13, 2018 CMS announced it will allow states to waive the much-maligned IMD exclusion in Medicaid, plus other healthcare headlines.
Experts: Drug prices likely to be center stage in 2020 election by Paige Minemyer Tuesday, November 13, 2018 HHS’ drug pricing plans are meant to signal to the healthcare industry—and voters—that it's serious on this issue, experts say.
Azar: Mandatory payment models “are going to see a comeback" by Rose Meltzer Thursday, November 8, 2018 HHS reduced the reach of its bundled payment models last November; some, it stopped entirely. Now, the agency is ready to create new, additional ones.
HHS faces providers skeptical of its new drug price plan by Paige Minemyer Friday, October 26, 2018 HHS' plan to bring down Part B prices has drawn skepticism, including from providers who helped sink a similar proposal from the Obama White House.
Another worry is a shortage of oncologists—Industry Voices by Amit Phull Thursday, October 18, 2018 Findings from a new study raised concerns around how cancer patients will be cared for in the future.
